Skip to main content
. 2021 Mar 23;29(4):662–671. doi: 10.1002/oby.23120

Figure 3.

Figure 3

PG pharmacotherapy for obesity management improves weight loss outcomes. (A) Percentage of patients achieving levels of weight loss after 1 year of either non‐PG (n = 228) or PG (n = 84) treatment. (B) The average percentage of total body weight loss from BSL in non‐PG (red circles) and PG (blue squares) treatment at 3, 6, and 12 months. **P < 0.01, ***P < 0.001. BSL, baseline; PG, phenotype guided.